期刊文献+

BCL11基因与恶性肿瘤的关系 被引量:2

BCL11 gene and malignant tumors
下载PDF
导出
摘要 B细胞淋巴瘤/白血病(B-cell lymphoma/leukemia,BCL)家族蛋白在细胞的增殖和抗凋亡等方面起重要作用。BCL11基因是BCL家族的成员之一,分为BCL11A和BCL11B基因。其中BCL11A基因是一种原癌基因,而BCL11B被认为是一种抑癌基因,近年来人们逐渐认识到了它们的结构与特点。越来越多的研究发现,它们不仅与血液系统淋巴细胞肿瘤的关系密切,还与很多其它系统的恶性肿瘤有着一定关系。本文主要介绍BCL11基因特点、功能,并结合最新的资料将其与人类各系统恶性肿瘤关系的研究做一综述。 The BCL( B-cell lymphoma/leukemia) family play a important role in the cell's proliferation and anti-apoptosis aspect. BCL11 gene is one member of the BCL family,including BCL11 A and BCL11 B gene. BCL11 A is a proto-oncogene,but BCL11 B is identified as an anti-oncogene. Recently,many researchers revealed their structure and characteristics. More and more studies showed that they not only had a close relationship with the malignant tumors of blood system,but also had something to do with other system's malignant tumors. In this review we will introduce the function and characteristics of the BCL11 gene,and also show its relationship with the different system's malignant tumors of human.
出处 《现代肿瘤医学》 CAS 2016年第8期1311-1315,共5页 Journal of Modern Oncology
基金 辽宁省自然科学基金(编号:2015020561) 中国医科大学附属第一医院科学研究基金(编号:fsfh1514)
关键词 BCL11A BAL11B 基因 恶性肿瘤 BCL11A BCL11B gene malignant tumors
  • 相关文献

参考文献1

二级参考文献10

  • 1Abla N,Chinn LW,Nakamura T,et al.The human multidrug resistance protein 4 (MRP4,ABCC4):functional analysis of a highly polymorphic gene.Pharmacol Exp Ther,2008,325:859-868.
  • 2Norris MD,Smith J,Tanabe K,et al.Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.Mol Cancer Ther,2005,4:547-553.
  • 3Peng XX,Shi Z,Damaraju VL,et al.Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine.Leuk Res,2008,32:799-809.
  • 4Nakamura T,Yamazaki Y,Saiki Y,et al.Evi9 encodes a novel zinc finger protein that physically interacts with BCL6,a known human B-cell proto-oncogene product.Mol Cell Boil,2000,20:3178-3186.
  • 5Liu H,Ippolito GC,Wall JK,et al.Functional studies of BCL11A:characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells.Mol Cancer,2006,5:18.
  • 6Simons-Evelyn M,Bailey-Dell K,Toretsky JA,et al.PBK/TOPK is a novel mitotic kinase which is unregulated in Burkett's lymphoma and other highly Proliferative malignant cells.Blood Cells Mol Dis,2001,27:825-829.
  • 7McClendon AK,Rodriguez AC,Osheroff N.Human topoisomerase Ⅰ alpha rapidly relaxes positively supercoiled DNA:implications for enzyme action ahead of replication forks.Biol Chem,2005,280:39337-39345.
  • 8J(a)rvinen TA,Liu ET.Simultaneous amplification of HER-2 (ERBB2) and topoisomerase Ⅱ alpha (TOP2A) genes-molecular basis for combination chemotherapy in cancer.Curr Cancer Drug Targets,2006,6:579-602.
  • 9Doussis-Anagnostopoulou IA,Vassilakopoulos TP,Thymara I,et al.Topoisomerase Ⅰ alpha expression as an independent prognostic factor in Hodgkin' s lymphoma.Clin Cancer Res,2008,14:1759-1766.
  • 10Guérin E,Entz-Werlé N,Eyer D,et al.Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia.Leukemia,2003,17:532-540.

共引文献1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部